European Journal of Clinical Pharmacology

, Volume 24, Issue 1, pp 93–98

The absolute bioavailability of caffeine in man

  • J. Blanchard
  • S. J. A. Sawers
Originals

Summary

The absolute bioavailability of orally administered caffeine was investigated in 10 healthy adult male volunteers, aged 18.8 to 30.0 years. The subjects were administered a 5 mg/kg dose of caffeine as either an aqueous oral solution or an intravenous infusion, on separate occasions about 1 week apart, in a randomized crossover fashion. Plasma samples were collected over the 24-h period following each dose and assayed for their caffeine content using a high-performance liquid chromatographic technique. The oral absorption was very rapid, reaching a peak (Tp) plasma concentration after 29.8±8.1 min (mean±SEM). In addition, the variation in the maximum plasma concentration (Cmax) was low, 10.0±1.0 µg/ml. The absolute bioavailability was assessed by comparing the areas under the plasma concentration vs. time curves for the intravenous and oral doses of caffeine. The rapid absorption resulted in essentially complete bioavailability of the oral caffeine, F(%)=108.3±3.6%. The caffeine plasma half-lives varied from 2.7 to 9.9 h, indicating substantial inter-subject variability in its elimination.

Key words

caffeine absolute bioavailability intraand inter-subject variability 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aldridge A, Parsons WD, Neims AH (1977) Stimulation of caffeine metabolism in the rat by 3-methylcholanthrene. Life Sci 21: 967–974Google Scholar
  2. 2.
    Aranda JV, Cook CE, Gorman W, Collinge JM, Loughnan PM, Outerbridge EW, Aldridge A, Neims AH (1979) Pharmacokinetic profile of caffeine in the premature newborn infant with apnea. J Pediatr 94: 663–668Google Scholar
  3. 3.
    Aranda JV, Gorman W, Bergsteinsson H, Gunn T (1977) Efficacy of caffeine in treatment of apnea in the low-birth-weight infant. J Pediatr 90: 467–472Google Scholar
  4. 4.
    Axelrod J, Reichenthal J (1953) The fate of caffeine in man and a method for its estimation in biological material. J Pharmacol Exp Ther 107: 519–523Google Scholar
  5. 5.
    Bada HS, Khanna NN, Somani SM, Tin AA (1979) Interconversion of theophylline and caffeine in newborn infants. J Pediatr 94: 993–995Google Scholar
  6. 6.
    Blanchard J, Mohammadi JD, Conrad KA (1980) Improved liquid-chromatographic determination of caffeine in plasma. Clin Chem 26: 1351–1354Google Scholar
  7. 7.
    Blanchard J, Mohammadi JD, Trang JM (1981) Elimination of a potential interference in assay for plasma caffeine. Clin Chem 27: 637–639Google Scholar
  8. 8.
    Boxenbaum HG, Riegelman S, Elashoff RM (1974) Statistical estimations in pharmacokinetics. J Pharmacokin Biopharm 2: 123–148Google Scholar
  9. 9.
    Chiou WL, Lui CY, Lam G (1981) Plasma area method in relative bioavailability evaluation of drugs with changing biological half-lives. J Pharm Sci 70: 109–112Google Scholar
  10. 10.
    Koup JR, Gibaldi M (1980) Some comments on the evaluation of bioavailability data. Drug Intell Clin Pharm 14: 327–330Google Scholar
  11. 11.
    Nelder JA, Mead R (1965) A simplex method for function minimization. Comput J 7: 308–313Google Scholar
  12. 12.
    Ottaway JH (1973) Normalization in the fitting of data by iterative methods. Biochem J 134: 729–736Google Scholar
  13. 13.
    Riggs DS (1963) The mathematical approach to physiological problems. Williams and Wilkins, Baltimore, MD, p 51Google Scholar
  14. 14.
    Rowland M (1980) Intra-individual variability in pharmacokinetics. In: Breimer DD (ed) Towards better safety of drugs and pharmaceutical products. Elsevier/North-Holland Biomedical Press, New York, pp 143–151Google Scholar
  15. 15.
    Tozer TN (1979) Pharmacokinetic principles relevant to bioavailability studies. In: Blanchard J, Sawchuk RJ, Brodie BB (eds) Principles and perspectives in drug bioavailability. Karger, Basel, pp 120–155Google Scholar
  16. 16.
    Upton RA, Riegelman S, Sheiner LB (1980) Bioavailability assessment as influenced by changes in drug disposition. In: Albert KS (ed) Drug absorption and disposition: statistical considerations. Am Pharm Assoc, Washington, DC, pp 77–86Google Scholar

Copyright information

© Springer-Verlag 1983

Authors and Affiliations

  • J. Blanchard
    • 1
  • S. J. A. Sawers
    • 2
  1. 1.Department of Pharmaceutical Sciences, College of PharmacyUniversity of ArizonaTucsonUSA
  2. 2.University Department of Therapeutics and Clinical PharmacologyThe Royal InfirmaryEdinburghScotland

Personalised recommendations